Isotopes Production – Framatome nuclide irradiation systems

A0733

Radionuclides are becoming vital components in modern medical diagnostics and therapy. A key method to produce these essential radionuclides is through neutron capture in nuclear power reactors.
Framatome’s Nuclide Activation Systems (NAS) enable target irradiation and radionuclide production in various types of pressurized water reactors and heavy water reactors.
Want to explore whether your reactor is suitable for Medical Isotopes Production? Leverage our expertise and discover the possibilities.

Sub-products

A1161

Neutron activation analyses

A0736

Target Manufacturing: sintered targets for isotopes Lu177/Mo99 production

Related solutions

Healthcare

Framatome Healthcare builds on our nuclear energy expertise and long-standing commitment in the field of nuclear medicine to advance medical products and services for the healthcare industry.
– With our CERCA division, world’s leading supplier of uranium fuel and targets for research reactors, and our Isogen joint-venture, specialized in producing medical radioisotopes in commercial Candu power reactors, we contribute to supply chains sustainability for the radioisotopes used in radiopharmaceuticals for diagnostic imaging and therapeutic purpose in cancer treatments.
– Framatome is active in modernizing and upgrading Cobalt-60 sterilization facilities based one our protected innovative technologies. Framatome can also offer new builds facilities together with partners, as well as services for those facilities.
– Based on our metallurgical expertise and industrial capabilities, we supply special alloys for surgical implants and prostheses.

medical/isotopes